Replies to post #238008 on Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

how can people not read this and connect the dots?


ARTHUR P. BERTOLINO, MD, PHD, MBA
President and Chief Medical Officer

Dr. Bertolino serves as President and Chief Medical Officer at Innovation. Dr. Bertolino is a leading pharmaceutical dermatology executive with over 15 years of domestic and global drug development and management experience. Previously, he was Vice President of Dermatology at Novartis, Vice President and Chief Medical Officer of Peplin, Inc., and Senior Director of Dermatology at Pfizer. Dr. Bertolino has authored over 50 abstracts, papers, and book chapters, and has been a regular on-air and in-print contributor to leading media companies. Dr. Bertolino received a BS (Chemistry / Biochemistry) degree from SUNY Stony Brook, an MD and PhD (Pharmacology) from The Johns Hopkins University School of Medicine, and an MBA from the University of Michigan Stephen M. Ross School of Business.

(copied from the IPIX website)

[scottsmith]

I would wonder why Leo wasted so much money running fda trials! Then I would ask how he plans to pay for anything. If Leo somehow pivots ipix to otc drugs but doesn’t get more cash from somewhere, ipix is still gonna go out of business. But the whole idea is absurd and quite frankly pathetic.

[PlentyParanoid]

You are maybe remembering Bertolino's presentation a year or two ago. If I remember correctly (no guarantee) he mentioned some surprising indications based on prurisol trial data at that point. I have feeling that he did not mean treatment for constipation or cancer.